Abstract At the age of 5 years, the prevalence of atopic manifestations was analysed in 58 formula-fed "at risk" infants because of a history of atopic disease in at least two first degree relatives. Infants were randomly assigned to receive either a partial whey-hydrolysate formula (n: 28) or a regular cow's milk formula (n: 30) during the first 6 months of life; thereafter, feeding was unrestricted. Only non-breastfed infants were included. The groups did not differ in risk factors or in known confounding factors possibly influencing the incidence of manifestations suggestive of atopic disease. At 6 months, the prevalence of cow's milk protein (CMP) sensitivity was significantly decreased in the hydrolysate group (7% versus 43%; P: 0.002). At the age of 12 (21% versus 53%; P: 0.029), 36 (25% versus 57%; P: 0.018) and 60 months (29% versus 60%; P: 0.016) there was still a significant difference in the number of atopic manifestations, if calculated cumulatively. There was no difference between the groups if only the new cases after the age of 6 months were considered. Eczema was less frequent in the whey-hydrolysate group, but only during the I st year of life, suggesting a decreased prevalence of CMP sensitivity. During the first 6 months, diarrhoea of non-infectious origin occurred in 8/30 infants (27%) of the adapted formula group, and in no infant in the hydrolysate group. "Colic as single manifestation" was considered of "allergic" origin in 1/28 infants in the hydrolysate group, and in 4/30 infants in the adapted formula group. If gastro-intestinal symptoms such as "diarrhoea and colic as single manifestation" are not considered, the number of infants with CMP sensitivity remains only significant for the first 6 months (P: 0.004). At 12, 36 and 60 months, differences are not significant (0.106, 0.116 and 0.07, respectively). The results of this study support the hypothesis that allergy prevention is antigen specific.
Conclusl n If mother s milk is not available and other studies confirm these results, there might be an ~n-dication for partial hydrolysates in infants with a family histow of atopy, since these formulae reduce the incidence of CMP sensitivity.
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Introduction
Mother's milk is the gold standard in infant feeding. If for some reason maternal milk is not available, (adapted) cow's milk is considered a good alternative. The estimated prevalence of cow's milk allergy is 3% to 6% in unselected, bottle-fed infants (Table 1) . As a consequence, cow's milk proteins (CMP) are the most frequent (food)allergens during early infancy. "Food intolerance" may play a role in the pathogenesis of some "allergic" or "atopic" disorders during infancy and early childhood [9, 24] . Exclusive breast feeding gives at least partial protection [2, 23] , although this is also controversial [14, 29] .
Results of studies on the short-term preventive effect of feeding a partial whey-hydrolysate, identical to the formula used in this study, to infants "at risk" for atopic disease because of a positive family history, were promising: the prevalence of manifestations suggestive of atopic disease was significantly decreased in the whey-hydrolysate group (WH-Gr), and similar to the incidence during exclusive breast feeding, in comparison to a group with a "regular" cow's milk based formula [6, 20, 26, [31] [32] [33] . Intermediary results of this study have been reported at 12 and 36 months [31, 33] . In this paper, the final data after a 5-year follow-up are presented.
Patients and methods
During a period of 14 months (1988) (1989) , in a total of about 2000 births, 75 infants with a positive family history in at least two first-degree relatives could be included in this study. Many parents with atopic disease refused participation because of the blood sampling at 6 months and the long-term follow-up, resulting in a particular study population. Parents and/or siblings had typical histories of atopic disease, supported by previously positive diagnostic tests. The mothers of these babies were strongly advised to breast feed. If breast feeding was refused, participation in this study was proposed. After randomisation, the infants were given one of two coded formulae (WH-Gr, or an adapted formula with native cow's milk proteins (AF-Gr)), delivered in an unlabelled package. Both formulae are marketed by Nestl6 (Table 2) . During the first 6 months of the study, 8 infants dropped out for various reasons: change of residence in 3 (2 WH-Gr, 1 AF-Gr), refusal of blood sampling at 6 months in 4 (1 WH-Gr, 3 AF-Gr), a switch to soy formula in 1 (1 WH-Gr). Between 6 and 12 months, 2 infants dropped out because of change of address. From the age of 3 years on, 58 infants remained in the study: an additional 7 infants had been lost during follow-up because of change of residence. No new drop-outs occulted during the last 2 years of the study. The final drop-out rate was 23%.
Details of the family history, IgE determination at day 5 and possibly confounding factors are listed in Table 3 , and were previously published in detail [33] . The infants were fed exclusively with the formula they had been assigned, on demand and at libitum during the first 6 months, with the exception of a grated apple daily that was given to all infants from the age of 4 months on. At the age of 6 months, a "normal" diversified diet without any restriction was given to al] babies except those who had developed symptoms suggesting CMP sensitivity. In these, the elimination diet, without CMP, egg, fish and soy, was continued up to the age of 12-15 months. A semi-elemental diet was administered up to this age in these children. All children were examined at least 15 times (each month during the first 6 months of life, each 6 months between the age of 6 months and 5 years). Whenever the children were sick, they were examined by the same team.
Follow-up was blinded as much as possible: neither the parents nor the physician(s) involved in the follow-up were informed about the nature of the formula. Both formulae (hydrolysate, regular formula) were given in blinded, unlabelled package. Nevertheless, it is obvious that a "partial hydrolysate" differs substantially in several aspects from a "regular folrnula".
The criteria for the diagnosis of CMP sensitivity have been published [33] , and are briefly summarised here. The following manifestations were considered: gastro-intestinal symptoms (recurrent colic, vomiting, and/or diarrhoea (2 episodes lasting > 2 days, when common eating problems, coincidental infections and lactose intolerance were excluded [ 1, 11 ] , urticaria, angio-oedema, atopic dermatitis, allergic rhinitis, asthma, chronic cough [15, 18, 25, 33] . Since the "allergic" origin of diarrhoea and "colic" is difficult to prove, the results were also analysed not accepting diarrhoea or colic as single manifestation of possible atopic origin.
Laboratory tests were performed in all infants at 6 months (IgE (Phadebas IgE Prist), RAST (Pharmacia Diagnostics, Uppsala, Sweden) for cow milk, casein, lactalbumin and lactoglobulin, skin prick test for cow milk (Bencard, Brentford, England) .
A challenge test, between 2 and 4 weeks after disappearance of the symptoms, was performed before cow's milk sensitivity was diagnosed: symptoms had to disappear on a semi-elemental highdegree whey-hydrolysate (Alfare, Nestl6), and to relapse when the original formula was reintroduced [25] . Lactose intolerance was excluded in infants presenting with diarrhoea or colic by determination of the lactase activity in the small bowel mucosa whenever a small bowel biopsy was performed, and a lactose breath test. In
